News
10-20-2010, 05:10 AM
The National Comprehensive Cancer Network® (NCCN®) recently updated the NCCN Clinical Practice Guidelines for Oncology (NCCN Guidelines?) for Breast Cancer to affirm the recommendation regarding the use of bevacizumab (Avastin®, Genentech/Roche) in the treatment of metastatic breast cancer...
More... (http://mnt.to/f/3LsD)
More... (http://mnt.to/f/3LsD)